Responsive hydrogel-based microneedle dressing for diabetic wound healing

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Endocrinology

Background:

• Diabetic wound healing is impaired by hyperglycemia and poor insulin delivery control.
• Current insulin injection methods offer limited therapeutic efficacy for diabetic complications.

Purpose of the Study:

• To develop a glucose-responsive insulin-releasing hydrogel microneedle dressing for enhanced diabetic wound management.
• To evaluate the efficacy of this novel dressing in accelerating wound healing and controlling blood glucose in diabetic models.

Main Methods:

• Fabrication of a hydrogel microneedle dressing using gelatin methacrylate (GelMa), a glucose-responsive monomer (AFPBA), and gluconic insulin (G-insulin).
• Characterization of the hydrogel's mechanical properties, biocompatibility, and glucose-responsive insulin release kinetics.
• In vivo assessment of the microneedle dressing's impact on diabetic wound healing, inflammation, collagen deposition, and glycemic control.

Main Results:

• The developed hydrogel microneedle dressing demonstrated good mechanical properties, biocompatibility, and controlled insulin release in response to glucose.
• The microneedle dressing showed superior skin adhesion compared to non-microstructured hydrogels.
• Accelerated diabetic wound healing was observed, characterized by reduced inflammation, increased collagen deposition, and improved blood glucose regulation.

Conclusions:

• Glucose-responsive insulin-releasing hydrogel microneedle dressings offer an effective strategy for diabetic wound management.
• This technology holds promise for treating chronic skin injuries and other conditions requiring controlled drug delivery.